The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.

Authors: Juan Feng, Yan Jiang, Ou Wang, Mei Li, Xiaoping Xing, Li Huo, Fang Li, Wei Yu, Ding-rong Zhong, Jin Jin, Yong Liu, Fang Qi, Wei Lv, Lian Zhou, Xun-wu Meng, Wei-bo Xia

Source: Endocrine Journal; 2017, Vol. 64 Issue 7, p675-683, 9p

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial.

Authors: Yan Jiang, Zhen-Lin Zhang, Zhong-Lan Zhang, Han-Min Zhu, Yi-Yong Wu, Qun Cheng, Feng-Li Wu, Xiao-Ping Xing, Jian-Li Liu, Wei Yu, Xun-Wu Meng

Source: Clinical Interventions in Aging; 2014, Vol. 9, p121-127, 7p

Subject Terms: POSTMENOPAUSE, OSTEOPOROSIS treatment, CHINESE women, BONE density, OSTEOCALCIN, CLINICAL trials, HEALTH

Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study.

Authors: Mei Li, Xiao-ping Xing, Zhen-lin Zhang, Jian-li Liu, Zhong-lan Zhang, Dong-gang Liu, Wei-bo Xia, Xun-wu Meng, Li, Mei, Xing, Xiao-ping, Zhang, Zhen-lin, Liu, Jian-li, Zhang, Zhong-lan, Liu, Dong-gang, Xia, Wei-bo, Meng, Xun-wu

Source: Journal of Bone & Mineral Metabolism; May2010, Vol. 28 Issue 3, p299-305, 7p, 1 Diagram, 2 Charts, 1 Graph

Subject Terms: BONE resorption, OSTEOPOROSIS in women, POSTMENOPAUSE, TREATMENT of bone diseases

Geographic Terms: CHINA

The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass.

Authors: Wei-bo XIA, Zhong-lan ZHANG, Hong-fu WANG, Xun-wu MENG, Ying ZHANG, Guo-ying ZHU, Xiao-ping XING, Jian-li LIU, Li-hua WANG, Yan JIANG, Shi-fang WENG, Tao XU, Ying-ying HU, Wei YU, Jun-ping TIAN

Source: Acta Pharmacologica Sinica; Mar2009, Vol. 30 Issue 3, p372-378, 7p, 4 Charts

Subject Terms: OLDER people, GERIATRICS, CHINESE people, WOMEN, BONES

Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis.

Authors: Yan Jiang, Yong Fu, Xiao ping Xing, Mei Li, Ou Wang, Wei bo Xia, Xun wu Meng

Source: European Journal of Medical Research; Aug2015, Vol. 20 Issue 1, p1-3, 3p

Subject Terms: OSTEOPOROSIS treatment, ZOLEDRONIC acid, HEPATOTOXICOLOGY, ALANINE aminotransferase, ASPARTATE aminotransferase, THERAPEUTICS